SAFETY AND IMMUNOGENICITY OF AGS-V, A MOSQUITO SALIVA PEPTIDE VACCINE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 TRIAL

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE(2018)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要